Respiratorius Q2 FY26 loss after financial items narrows to SEK 1.78 million; net sales show no revenue
Reuters2026/08/11 06:31- Respiratorius posted no net sales in Q2 2026, while loss after financial items narrowed to SEK 1.78 million from SEK 1.81 million.
- Earnings per share improved to SEK -0.23 from SEK -0.35, while equity ratio rose to 99.01% from 96.12% a year earlier.
- For H1 2026, loss after financial items narrowed to SEK 3.51 million from SEK 3.81 million, while EPS improved to SEK -0.44 from SEK -0.75.
- Management said multiple partnering meetings led counterparties to evaluate VAL001, while the company will present at Nordic Star 2026 Pitch Competition in September.
- Funding is expected to cover operations through February 2027, with the company continuing to run a cost-conscious, efficient resource plan.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Goldman Sachs evaluates Apple's foldable iPhone: Pricing is “affordable,” with shipments this year reaching up to 35 million units
A Goldman Sachs report indicates that iPhone Duo, with its "thinnest ever" design and "affordable" pricing, is expected to open up the mass market. The forecast for 2026 remains at 14 to 35 million units shipped. The new product's upgrades in hinges, cooling, and camera technologies will benefit the supply chain in Greater China, including Foxconn.
Nissan reorganizes Japan manufacturing footprint, shifts vehicle production among plants
Sekisui Chemical housing order value falls 4% in August, units down 6%
Austevoll Seafood board member Hege Solbakken resigns after Vestland county governor appointment
Crypto prices
More
